Año de edición:
N. de edición:
Disponible en 2-3 semanas




167,00 €


158,65 €

• Section 1: Hallmarks of Cancer
1: The hallmarks of cancer,
2: Growth factors and uncontrolled proliferation,
3: Cell signalling pathways,
4: Cell cycle control,
5: Cancer cell death,
6: Angiogenesis,
7: Invasion and metastases,
8: Genetic instability,
9: DNA repair after oncological therapy,
10: Biology of cancer stem cells,
11: Biomarker identification and clinical validation,
12: Cancer, immunity, and inflammation,
13: Cancer and metabolism,
• Section 2: Etiology and Epidemiology of Cancer
14: Smoking and cancer,
15: Viruses,
16: Chemical carcinogens,
17: Radiation,
18: Body fatness, physical activity, diet, and other lifestyle factors,
• Section 3: Principles of Oncology
19: Practice points for surgical oncology,
20: Practice points for radiation oncology,
21: Principles of chemotherapy,
22: Delivery of multidisciplinary cancer care,
23: Principles of clinical pharmacology: Introduction to pharmacokinetics and pharmacodynamics,
24: Design and analysis of clinical trials,
25: Medical ethics in oncology,
26: Health economic assessment of cancer therapy,
• Section 4: Population Health
27: Cancer control: The role of national plans,
28: Cancer prevention: Vaccination,
29: Cancer prevention: Chemoprevention,
30: Population cancer screening,
31: Familial cancer syndromes and genetic counselling,
• Section 5: Support for the cancer patient
32: Supportive palliative care,
33: Quality of life,
34: Cancer survivorship and rehabilitation,
• Section 6: Disease
35: Cancer of the head and neck,
36: Oesophageal cancer,
37: Gastric cancer,
38: Rectal cancer,
39: Colon cancer,
40: Pancreatic cancer,
41: Hepatobiliary cancer,
42: Peritoneal mesothelioma,
43: Cancer of the breast,
44: Gynaecological cancers,
45: Genitourinary cancer,
46: Lung cancer,
47: Neoplasms of the thymus,
48: Pleural mesothelioma,
49: Skin cancer: melanoma,
50: Skin cancer: non-melonoma,
51: Acute leukemia,
52: Chronic leukemias,
53: Myeloma,
54: Lymphomas,
55: Sarcomas of the soft tissue,
56: Cancer of the central nervous system,
57: Cancer of the eye and orbit,
58: Endocrine cancers,
59: Cancer of unknown primary site,

Now in paperback, the Oxford Textbook of Oncology reflects current best practice in the multidisciplinary management of cancer, written and edited by internationally recognised leaders in the field.
Structured in six sections, the book provides an accessible scientific basis to the key topics of oncology, examining how cancer cells grow and function, as well as discussing the aetiology of cancer, and the general principles governing modern approaches to oncology treatment. The book examines the challenges presented by the treatment of cancer on a larger scale within population groups, and the importance of recognising and supporting the needs of individual patients, both during and after treatment.
A series of disease-oriented, case-based chapters, ranging from acute leukaemia to colon cancer, highlight the various approaches available for managing the cancer patient, including the translational application of cancer science in order to personalise treatment. The advice imparted in these cases has relevance worldwide, and reflects a modern approach to cancer care.
The Oxford Textbook of Oncology provides a comprehensive account of the multiple aspects of best practice in the discipline, making it an indispensable resource for oncologists of all grades and subspecialty interests.

• Newly available in paperback
• Highly commended at the BMA Medical Book Awards 2016
• Multidisciplinary outlook defines the importance of a team approach to cancer, reflecting actual practice
• Expert and authoritative writers from around the world ensure the content is relevant to current cancer medicine and represents global perspectives
• Accessible basic science sections which demonstrate the link between research and translation into novel therapy
• Extensive clinical cases section brings the textbook to life with real life cases managed by experts
• Both disease-oriented and comprehensive, the textbook provides information on a range of topics, including ethics, prevention, carcinogenesis, and health economics

• David J. Kerr, Professor of Cancer Medicine, Nuffield Division of Clinical Laboratory Sciences, Nuffield Department of Medicine, University of Oxford, Oxford, UK, Honorary Professor of Oncology, Xiamen and 2nd Military Universities, China, Honorary Professor, Seoul National University, Korea.
• Daniel G. Haller, Professor Emeritus, Perelman School of Medicine, University of Pennsylvania, Philadelphia, USA.
• Cornelis J. H. van de Velde, Professor of Surgery and Head, Department of Surgical Oncology, Leiden University Medical Center, The Netherlands.
• Michael Baumann, Cancer Research Center (DKFZ), Heidelberg, Germany and Department of Radiotherapy and Radiation Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Germany